GNFT vs. MRK

In the year-to-date period, GNFT achieves a 21.40% return, which is significantly higher than MRK's -22.09% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Genfit (GNFT) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GNFT Sharpe Ratio is -0.34, which is higher than the MRK Sharpe Ratio of -1.32. The chart below compares the historical Sharpe Ratios of GNFT and MRK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GNFT has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 4.11%.

The maximum GNFT drawdown since its inception was -89.42%, which is greater than MRK's maximum drawdown of -68.63%. Use the drawdown chart below to compare losses from any high point for GNFT and MRK.

Genfit (GNFT) has a higher volatility of 15.01% compared to Merck & Co., Inc. (MRK) at 11.25%. This indicates that GNFT's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Genfit and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.